Understanding how early mouse embryos decide their cell types
Temporal program for cell fate specification in the mouse embryo
This study looks at how mouse embryos decide to form two important parts: the placenta and the fetus, by examining the early steps of cell behavior and communication, which could help us understand more about how mammals develop and improve reproductive technologies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | California Institute of Technology NIH-funded |
| Lab location | 1 site (Pasadena, United States) |
| Project ID | NIH-10881811 on NIH RePORTER |
What this research studies
This research investigates the initial decision-making process in mouse embryos that leads to the formation of two distinct cell types: those that will develop into the placenta and those that will become the fetus. By focusing on the mechanisms of cell polarization, the study aims to uncover the upstream regulators that trigger this crucial developmental step. The researchers will explore the roles of specific transcription factors and cytoskeletal activity in this process, using advanced techniques to analyze cell behavior and signaling pathways. This work could provide insights into early mammalian development and potential implications for reproductive technologies.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals undergoing assisted reproductive technologies or those interested in the mechanisms of early embryonic development.
Not a fit: Patients with established pregnancies or those not seeking reproductive assistance may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of early embryonic development, potentially improving assisted reproductive technologies.
How similar studies have performed: Previous research has shown success in understanding cell polarization and fate specification in other model organisms, suggesting potential for similar breakthroughs in mammalian studies.
Where this research is happening
Pasadena, United States
- California Institute of Technology — Pasadena, United States (Active)
Researchers
- Principal investigator: Zernicka-Goetz, Magdalena — California Institute of Technology
- Study coordinator: Zernicka-Goetz, Magdalena
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.